What oral valacyclovir dose is equivalent to 200 mg oral acyclovir in an adult with normal renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Valacyclovir 500 mg once daily is approximately equivalent to acyclovir 200 mg three times daily in an adult with normal renal function.

For practical dose conversion: acyclovir 200 mg given 3-5 times daily can be replaced with valacyclovir 500 mg once or twice daily, depending on the indication.

Pharmacokinetic Basis for Conversion

Valacyclovir is the L-valine ester prodrug of acyclovir that achieves 3-5 times higher acyclovir bioavailability compared to oral acyclovir 1, 2, 3. After oral administration, valacyclovir is rapidly converted to acyclovir through first-pass intestinal and hepatic metabolism 1.

The absolute bioavailability of acyclovir is:

  • 54.5% from valacyclovir 1
  • 26.7% from acyclovir capsules 2

This means valacyclovir delivers approximately twice the systemic acyclovir exposure per milligram compared to oral acyclovir 2.

Specific Dose Equivalencies by Indication

For Genital Herpes Treatment

  • Acyclovir 200 mg 5 times daily = Valacyclovir 1000 mg twice daily 1, 4, 5
  • Clinical trials demonstrated equivalent efficacy for lesion healing (median 9 days for both), cessation of pain (5 days), and viral shedding (3 days) 1, 5

For Genital Herpes Suppression

  • Acyclovir 400 mg twice daily = Valacyclovir 500-1000 mg once daily 1
  • At 12 months, both regimens kept 34% of patients recurrence-free versus 4% with placebo 1

For Herpes Labialis (Cold Sores)

  • Acyclovir 200 mg 5 times daily can be replaced with Valacyclovir 2000 mg twice daily for 1 day 1

Mathematical Conversion for 200 mg Acyclovir

Given the bioavailability difference:

  • Acyclovir 200 mg delivers approximately 53 mg of systemic acyclovir (26.7% bioavailability)
  • To match this with valacyclovir: 53 mg ÷ 0.545 = 97 mg of valacyclovir needed
  • However, valacyclovir contains only 69.4% acyclovir by weight 2
  • Practical equivalent: Valacyclovir 150-200 mg would theoretically match acyclovir 200 mg

In clinical practice, the smallest valacyclovir dose is 500 mg, which exceeds the exposure from acyclovir 200 mg by 2-3 fold. This is why valacyclovir dosing frequency is reduced (once or twice daily vs. 3-5 times daily for acyclovir).

Renal Dosing Considerations

Both drugs require adjustment in renal impairment 6, 7, 6:

For CrCl <30 mL/min:

  • Acyclovir 200 mg: reduce to 200 mg every 12 hours 6
  • Valacyclovir 500 mg: reduce to 500 mg every 24-48 hours 6, 7, 6

For hemodialysis:

  • Acyclovir: 200 mg every 12 hours, dose after dialysis 6
  • Valacyclovir: 500 mg after each dialysis 6, 7

Clinical Caveats

  • No direct 1:1 conversion exists because valacyclovir's superior bioavailability allows less frequent dosing rather than equivalent single-dose substitution
  • The improved bioavailability translates to convenience (fewer daily doses) rather than lower total daily drug amounts 4, 8, 3
  • Compliance is significantly better with valacyclovir's twice-daily regimen versus acyclovir's 5-times-daily schedule 4, 8
  • High-dose valacyclovir (≥3 g/day) carries risk of thrombocytopenia and neurotoxicity, particularly in elderly patients or those with renal impairment 9, 10

References

Research

Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique, 2001

Research

Valaciclovir: development, clinical utility and potential.

Expert opinion on investigational drugs, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.